NYAS Meeting on TB – April 6, 2010

22 Mar 2010
by Working Group

nyas logo

In more than 10 years since the sequence of the Mycobacterium tuberculosis genome was published, the genetic information of the pathogen and genetic tools have shifted the emphasis of TB drug research. This symposium highlights how they are utilized in the quest for novel TB regimens.

This meeting will be presented by the Emerging Infectious Diseases and Microbiology Discussion Group at the New York Academy of Sciences.

Speakers include:

  • Helen Boshoff (NIH)
  • William R. Jacobs, JR. (Albert Einstein college of Medicine)
  • Carl Nathan (Weill Cornell Medical College)
  • Christopher Sassetti (University of Massachusetts Medical School)
  • Dirk Schnappinger (Weill Cornell Medical College)

The meeting is organized by Takushi Kaneko (TB Alliance) and Jennifer Henry (NYAS).

For more information and to register, please visit An online webinar is also available if you are unable to attend in person.

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...